Cannabidiol prescribing in the United States: An analysis of real-world data

Cannabidiol prescribing in the United States: An analysis of real-world data

Background: Off-label prescribing of Epidiolex® (pharmaceutical cannabidiol) comes with both potential benefits and risks for patients. The aims of this study were to: (1) identify the percentage of people prescribed Epidiolex® who do not have diagnostic indications for Epidiolex® (Lennox Gastaut Sy...

Full description

Saved in:
Bibliographic Details
Main Authors: Binx Yezhe Lin, Chloe Lessard, Yifan Li, Lisa Gong, Ruth Ling, Pallawi Jyotsana, Jacob Steinle, Jacob T. Borodovsky, Fábio A. Nascimento, Kevin Y. Xu
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Drug and Alcohol Dependence Reports
Subjects:
Cannabidiol
Cannabis
Medical marijuana
Routinely collected health data
Health services research
Online Access:http://www.sciencedirect.com/science/article/pii/S2772724624000878
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2772724624000878

Similar Items